FDA backs Roche Gazyva in first-line follicular lymphoma Ruby Khatun Khatun20 Nov 2017 4:00 AM GMTZURICH: The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma,...